Illumina Launches TruSight Oncology 500 for Pan-Cancer Tumor Profiling
The assay enables researchers to measure tumor mutational burden and microsatellite instability, and detect other known and emerging biomarkers.
Read MoreSearch Results for: lung cancer
National Cancer Institute Grants Support Liquid Biopsy Studies
With three NCI grants, BioFluidica is investigating chip-based liquid biopsy technologies for the detection of cancer and related genetic variants.
Read More
Natera and Neon Therapeutics Collaborate to Assess Treatment Response to Personal Cancer Vaccine
The partners’ study combines Neon’s personal neoantigen vaccine and Signatera’s circulating tumor DNA assay in a trial for metastatic non-small cell lung cancer.
Read More
Protagen and German National Center for Tumor Diseases, Heidelberg, to Investigate Immunocompetence of Cancer Patients
Protagen has extended its collaboration with the National Center for Tumor Diseases, Heidelberg, to investigate the immunocompetence of urothelial cancer patients receiving immunotherapy.
Read More
Biodesix Pipeline Test Demonstrates Utility in Triaging Patients with Lung Nodules
Independent study data show noninvasive test could eliminate the biopsy needle and reduce both patient anxiety and costs.
Read More